Review finds ADHD drugs may ease perimenopause brain fog and improve daily focus, but objective cognition gains remain unclear; larger safety and efficacy studies needed.
|Slideshows|November 4, 2015
Deconstructing ADHD, Addiction, and Beyond
Author(s)Anthony M. Ocana, MD, MSc
Listen
0:00 / 0:00
News and research highlights on ADHD, conduct disorder, substance use disorder, and behavioral addictions, including compulsive social networking.
Advertisement
 Dr Anthony Ocana summarizes the latest news and research highlights on ADHD. Scroll through the slides for sources. To view in PDF format, click here.
Advertisement
Related to this article
Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.
APSARD is preparing US adult ADHD guidelines, delivering long-awaited screening, diagnosis, and treatment recommendations as experts discuss the upcoming release.
Advertisement
Advertisement
Trending on Psychiatric Times
1
When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice
2
Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship
3
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
4
FDA Aligns on Key Elements of Phase 3 Study of Zervimesine for Dementia With Lewy Bodies
5